Pri-Med Podcasts

The How-To’s of Managing Drug-Drug Interactions in Non-Hospitalized Patients with COVID-19

Credits: 0.50 AMA PRA Category 1 Credit™  CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/managing-drug-drug-interactions-non-hospitalized-patients  
Overview: This in-depth discussion provides guidance on the options available to clinicians for managing potential drug-drug interactions in non-hospitalized patients with COVID-19. Hear practical strategies for increased monitoring, dosage adjustments, and exploring alternative medications to enable the safe use of anti-COVID-19 therapies. Faculty also discuss when consultation with a pharmacist and/or patient’s specialist is advised. 

Treatment for Non-Hospitalized Patients with COVID-19

Credits: 0.25 AMA PRA Category 1 Credit™  CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/treatment-non-hospitilized-patients-covid-19 
Overview: Join expert faculty as they discuss risk stratification for non-hospitalized patients with mild or moderate COVID-19 to determine who would benefit most from antiviral therapy aimed at reducing the risk of progression to severe disease. Explore national guideline recommendations on COVID-19 treatment in non-hospitalized patients, including factors to consider when selecting therapy for individual patients. 

Clearing the Air: Are Antibiotics Necessary for Childhood Sinusitis?

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-354
Overview: There is an overlap of acute sinusitis symptoms and viral upper respiratory tract infection, such that many children are treated unnecessarily with antibiotics. In this episode, we review 2 recent studies that inform recommendations on whether or not to treat childhood sinusitis with amoxicillin/clavulanate. Gain practical strategies and the confidence to appropriately address sinusitis in the children you treat.
Episode resource links:
JAMA. 2023;330(4):349-358. doi:10.1001/jama.2023.10854
JAMA. 2023;330(11):1064-1073. doi:10.1001/jama.2023.15503
Journal of Pediatrics, The, 2019-04-01, Volume 207, Pages 103-108.e1
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

Ask The Expert About Pain Management

Credits: 0.50 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/pain-management-ask-the-expert 
Overview: In this podcast, Dr Katherine Galluzzi will answer frequently asked questions regarding opioid therapy, such as: Best practices for tapering opioids; Assessing for opioid use disorder and distinguishing between tolerance, dependence, misuse, and abuse; Strategies for counseling patients with pain; Nonpharmacologic and non-opioid treatment options; and What to do when a patient approaches the “ceiling” of safe opioid dosing.
This  activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

RSV in Infants: An Ounce of Prevention - Frankly Speaking Ep 353

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-353
Overview: Bronchiolitis caused by respiratory syncytial virus (RSV) infection in infants is common and can lead to hospitalization if severe. There are now 2 ways to prevent this: immunizing the mother during pregnancy or giving monoclonal antibodies. Listen in as we discuss the recommendations for RSV prevention and how to best incorporate them into your practice.
Episode resource links:
Fleming-Dutra KE, Jones JM, Roper LE, et al. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:1115–1122.
Jones JM, Fleming-Dutra KE, Prill MM, et al. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:920–925
Kampmann B, Madhi SA, Munjal I, et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023;388(16):1451-1464.
Guest: Alan M. Ehrlich MD, FAAFP Music Credit: Richard Onorato

From Hype to Hope: COVID-19 Outpatient Treatment Recommendations - Frankly Speaking Ep 352

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-352
Overview: Keep your practice at the forefront of outpatient COVID-19 management with this informative episode. Listen in as expert faculty discuss the latest recommendations and review ineffective treatments, helping you provide the best care during this new phase of the endemic.
Episode resource links:
https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/clinical-management-of-adults-summary/?utm_source=site&utm_medium=home&utm_campaign=highlights
Abdool Karim, S. S., & Devnarain, N. (2022). Time to stop using ineffective COVID-19 drugs. New England Journal of Medicine, 387(7), 654-655.
Hayden, M. K., Hanson, K. E., Englund, J. A., Lee, F., Lee, M. J., Loeb, M., ... & Mustafa, R. A. (2023). The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing. Clinical Infectious Diseases, ciad032.
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato

Proven Strategies for Optimal Pain Management Outcomes in Special Populations: The Management of Knee OA in a Patient with Cardiovascular Disease

Credits: 0.50 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/pain-management-outcomes-special-populations 
Overview: Tapering opioids is frequently necessary in clinical practice, either to reduce harm or because of lack of significant benefit. The most important aspect of opioid tapering is discussing the reasons for it with the patient. Opioid tapering should be a measure of safety—and in no way punitive. Complete this activity to learn appropriate and inappropriate reasons for tapering opioid therapy and strategies to counsel patients and manage withdrawal and psychological issues.
This  activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Screen Time and Developmental Delays in Children - Frankly Speaking Ep 351

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-351
Overview: Live at Pri-Med East! In this episode, we will examine the association of developmental delays with amount of screen time in children.
Episode resource links:
https://jamanetwork.com/journals/jamapediatrics/fullarticle/2808593
https://www.aap.org/en/patient-care/media-and-children/center-of-excellence-on-social-media-and-youth-mental-health/social-media-and-youth-mental-health-q-and-a-portal/middle-childhood/middle-childhood-questions/screen-time-guidelines/
https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx
Guest: Jillian Joseph, MSPAS, PA-CMusic Credit: Richard Onorato

Breaking the Opioid Cycle: A Practical Training Program for Tapering Opioids in Primary Care

Credits: 0.50 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/pain-management-breaking-opioid-cycle 
Overview: Tapering opioids is frequently necessary in clinical practice, either to reduce harm or because of lack of significant benefit. The most important aspect of opioid tapering is discussing the reasons for it with the patient. Opioid tapering should be a measure of safety—and in no way punitive. Complete this activity to learn appropriate and inappropriate reasons for tapering opioid therapy and strategies to counsel patients and manage withdrawal and psychological issues.
This  activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdffor a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Cracking into the Evidence: Does Eating Nuts Affect Cognitive Performance? - Frankly Speaking Ep 350

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-350
Overview: Nuts have a reputation for providing a variety of health benefits, but how far do their nutritional superpowers reach? In this episode, we take a look at the findings of a study showing the association between nut consumption and cognitive performance. Listen in as expert faculty discuss the implications for managing patients at risk for cognitive decline.
Episode resource links:
The American Journal of Clinical Nutrition https://doi.org/10.1016/j.ajcnut.2023.05.032
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato